Articles related to Oncology, Medical

The annual cost of cancer screening represents a notable portion of overall U.S. health care system costs related to cancer, with private insurance covering the majority of expenses.

Afamitresgene autoleucel offers a novel approach to treating metastatic synovial sarcoma, with an overall response rate of 43.2% in clinical trials, providing a much-needed alternative to traditional chemotherapy.

The FDA advisory committee’s decision highlights the complexities of perioperative treatment in NSCLC and the need for more precise efficacy data to guide clinical decision-making.

Frailty assessment enables clinicians to predict outcomes, target interventions, and tailor clinical management for older adults, potentially improving care quality and patient outcomes.

Age bias in oncology can lead to younger patients receiving more aggressive treatments with marginal survival benefits, potentially compromising their quality of life.

Infrequent soft stools were associated with higher risks of all-cause, cancer, and cardiovascular disease mortality, suggesting that stool monitoring could be a valuable indicator of major chronic illnesses.